NCT07632742
Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial
Recruiting
NAAges 18+InterventionalTreatmentNorthwestern UniversityInvestigator-initiated
~180 participants
Updated 2026-06-08 on ClinicalTrials.gov
What's tested:Magneto 150 holmium laserMoses 2.0 holmium laser
At a glance
Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mean hemostasis time
Measured over During surgery
Conditions
Where it's being run
1 sites across 1 statesIllinois1
Study leadership
- Perry Xu, MD · PRINCIPAL_INVESTIGATOR · Northwestern University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms
Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer)
Exclusion
Patients who lack decisional capacity
Patients unable to read/speak English
Patients who are on a blood thinner (anticoagulation medication)
Patients who do not have internet access to complete postoperative surveys
What this trial measures
- Mean hemostasis timeDuring surgery
Overall intraoperative hemostasis time